Serum brain-derived neurotrophic factor and antidepressant-naive major depression after lung cancer diagnosis

Makoto Kobayakawa, Masatoshi Inagaki, Maiko Fujimori, Kei Hamazaki, Tomohito Hamazaki, Tatsuo Akechi, Shoichiro Tsugane, Yutaka Nishiwaki, Koichi Goto, Kenji Hashimoto, Shigeto Yamawaki, Yosuke Uchitomi

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Previous studies have reported the existence of an association between brain-derived neurotrophic factor and major depression. However, the possible role of brain-derived neurotrophic factor in the pathophysiology of major depression after cancer diagnosis has not yet been investigated. Subjects were collected using the Lung Cancer Database project. Using the cut-off scores on the depression subscale of the Hospital Anxiety and Depression Scale (HADS-D), 81 subjects with depression (HADS-D > 10) and 81 subjects without depression (HADS-D <5) were selected. The two groups were matched for age, sex, clinical stage and performance status. The serum brain-derived neurotrophic factor levels were measured using an enzyme-linked immunosorbent assay method. The serum brain-derived neurotrophic factor levels were not statistically different between the subjects in the depression group [29.1 (13.6) ng/ml; mean (SD)] and the non-depression group [31.4 (10.6) ng/ml] (P = 0.22). In a stratified analysis by gender, however, the mean serum brain-derived neurotrophic factor level in the depression group tended to be lower than that in the non-depression group among women (n = 24 pairs, P = 0.06). Major depression after cancer diagnosis is not associated with serum brain-derived neurotrophic factor levels.

Original languageEnglish
Article numberhyr119
Pages (from-to)1233-1237
Number of pages5
JournalJapanese Journal of Clinical Oncology
Volume41
Issue number10
DOIs
Publication statusPublished - Oct 2011
Externally publishedYes

Fingerprint

Brain-Derived Neurotrophic Factor
Antidepressive Agents
Lung Neoplasms
Depression
Serum
Neoplasms
Research Design
Anxiety
Enzyme-Linked Immunosorbent Assay
Databases

Keywords

  • BDNF
  • Cancer diagnosis
  • Lung cancer
  • Major depression
  • Stressful event

ASJC Scopus subject areas

  • Oncology
  • Cancer Research
  • Radiology Nuclear Medicine and imaging

Cite this

Kobayakawa, M., Inagaki, M., Fujimori, M., Hamazaki, K., Hamazaki, T., Akechi, T., ... Uchitomi, Y. (2011). Serum brain-derived neurotrophic factor and antidepressant-naive major depression after lung cancer diagnosis. Japanese Journal of Clinical Oncology, 41(10), 1233-1237. [hyr119]. https://doi.org/10.1093/jjco/hyr119

Serum brain-derived neurotrophic factor and antidepressant-naive major depression after lung cancer diagnosis. / Kobayakawa, Makoto; Inagaki, Masatoshi; Fujimori, Maiko; Hamazaki, Kei; Hamazaki, Tomohito; Akechi, Tatsuo; Tsugane, Shoichiro; Nishiwaki, Yutaka; Goto, Koichi; Hashimoto, Kenji; Yamawaki, Shigeto; Uchitomi, Yosuke.

In: Japanese Journal of Clinical Oncology, Vol. 41, No. 10, hyr119, 10.2011, p. 1233-1237.

Research output: Contribution to journalArticle

Kobayakawa, M, Inagaki, M, Fujimori, M, Hamazaki, K, Hamazaki, T, Akechi, T, Tsugane, S, Nishiwaki, Y, Goto, K, Hashimoto, K, Yamawaki, S & Uchitomi, Y 2011, 'Serum brain-derived neurotrophic factor and antidepressant-naive major depression after lung cancer diagnosis', Japanese Journal of Clinical Oncology, vol. 41, no. 10, hyr119, pp. 1233-1237. https://doi.org/10.1093/jjco/hyr119
Kobayakawa, Makoto ; Inagaki, Masatoshi ; Fujimori, Maiko ; Hamazaki, Kei ; Hamazaki, Tomohito ; Akechi, Tatsuo ; Tsugane, Shoichiro ; Nishiwaki, Yutaka ; Goto, Koichi ; Hashimoto, Kenji ; Yamawaki, Shigeto ; Uchitomi, Yosuke. / Serum brain-derived neurotrophic factor and antidepressant-naive major depression after lung cancer diagnosis. In: Japanese Journal of Clinical Oncology. 2011 ; Vol. 41, No. 10. pp. 1233-1237.
@article{eda1ccdb0d154f13b823cf2955b2beee,
title = "Serum brain-derived neurotrophic factor and antidepressant-naive major depression after lung cancer diagnosis",
abstract = "Previous studies have reported the existence of an association between brain-derived neurotrophic factor and major depression. However, the possible role of brain-derived neurotrophic factor in the pathophysiology of major depression after cancer diagnosis has not yet been investigated. Subjects were collected using the Lung Cancer Database project. Using the cut-off scores on the depression subscale of the Hospital Anxiety and Depression Scale (HADS-D), 81 subjects with depression (HADS-D > 10) and 81 subjects without depression (HADS-D <5) were selected. The two groups were matched for age, sex, clinical stage and performance status. The serum brain-derived neurotrophic factor levels were measured using an enzyme-linked immunosorbent assay method. The serum brain-derived neurotrophic factor levels were not statistically different between the subjects in the depression group [29.1 (13.6) ng/ml; mean (SD)] and the non-depression group [31.4 (10.6) ng/ml] (P = 0.22). In a stratified analysis by gender, however, the mean serum brain-derived neurotrophic factor level in the depression group tended to be lower than that in the non-depression group among women (n = 24 pairs, P = 0.06). Major depression after cancer diagnosis is not associated with serum brain-derived neurotrophic factor levels.",
keywords = "BDNF, Cancer diagnosis, Lung cancer, Major depression, Stressful event",
author = "Makoto Kobayakawa and Masatoshi Inagaki and Maiko Fujimori and Kei Hamazaki and Tomohito Hamazaki and Tatsuo Akechi and Shoichiro Tsugane and Yutaka Nishiwaki and Koichi Goto and Kenji Hashimoto and Shigeto Yamawaki and Yosuke Uchitomi",
year = "2011",
month = "10",
doi = "10.1093/jjco/hyr119",
language = "English",
volume = "41",
pages = "1233--1237",
journal = "Japanese Journal of Clinical Oncology",
issn = "0368-2811",
publisher = "Oxford University Press",
number = "10",

}

TY - JOUR

T1 - Serum brain-derived neurotrophic factor and antidepressant-naive major depression after lung cancer diagnosis

AU - Kobayakawa, Makoto

AU - Inagaki, Masatoshi

AU - Fujimori, Maiko

AU - Hamazaki, Kei

AU - Hamazaki, Tomohito

AU - Akechi, Tatsuo

AU - Tsugane, Shoichiro

AU - Nishiwaki, Yutaka

AU - Goto, Koichi

AU - Hashimoto, Kenji

AU - Yamawaki, Shigeto

AU - Uchitomi, Yosuke

PY - 2011/10

Y1 - 2011/10

N2 - Previous studies have reported the existence of an association between brain-derived neurotrophic factor and major depression. However, the possible role of brain-derived neurotrophic factor in the pathophysiology of major depression after cancer diagnosis has not yet been investigated. Subjects were collected using the Lung Cancer Database project. Using the cut-off scores on the depression subscale of the Hospital Anxiety and Depression Scale (HADS-D), 81 subjects with depression (HADS-D > 10) and 81 subjects without depression (HADS-D <5) were selected. The two groups were matched for age, sex, clinical stage and performance status. The serum brain-derived neurotrophic factor levels were measured using an enzyme-linked immunosorbent assay method. The serum brain-derived neurotrophic factor levels were not statistically different between the subjects in the depression group [29.1 (13.6) ng/ml; mean (SD)] and the non-depression group [31.4 (10.6) ng/ml] (P = 0.22). In a stratified analysis by gender, however, the mean serum brain-derived neurotrophic factor level in the depression group tended to be lower than that in the non-depression group among women (n = 24 pairs, P = 0.06). Major depression after cancer diagnosis is not associated with serum brain-derived neurotrophic factor levels.

AB - Previous studies have reported the existence of an association between brain-derived neurotrophic factor and major depression. However, the possible role of brain-derived neurotrophic factor in the pathophysiology of major depression after cancer diagnosis has not yet been investigated. Subjects were collected using the Lung Cancer Database project. Using the cut-off scores on the depression subscale of the Hospital Anxiety and Depression Scale (HADS-D), 81 subjects with depression (HADS-D > 10) and 81 subjects without depression (HADS-D <5) were selected. The two groups were matched for age, sex, clinical stage and performance status. The serum brain-derived neurotrophic factor levels were measured using an enzyme-linked immunosorbent assay method. The serum brain-derived neurotrophic factor levels were not statistically different between the subjects in the depression group [29.1 (13.6) ng/ml; mean (SD)] and the non-depression group [31.4 (10.6) ng/ml] (P = 0.22). In a stratified analysis by gender, however, the mean serum brain-derived neurotrophic factor level in the depression group tended to be lower than that in the non-depression group among women (n = 24 pairs, P = 0.06). Major depression after cancer diagnosis is not associated with serum brain-derived neurotrophic factor levels.

KW - BDNF

KW - Cancer diagnosis

KW - Lung cancer

KW - Major depression

KW - Stressful event

UR - http://www.scopus.com/inward/record.url?scp=80053501842&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80053501842&partnerID=8YFLogxK

U2 - 10.1093/jjco/hyr119

DO - 10.1093/jjco/hyr119

M3 - Article

VL - 41

SP - 1233

EP - 1237

JO - Japanese Journal of Clinical Oncology

JF - Japanese Journal of Clinical Oncology

SN - 0368-2811

IS - 10

M1 - hyr119

ER -